Full-Time

Organ Health Specialist

Updated on 2/1/2025

Natera

Natera

1,001-5,000 employees

Genetic testing and diagnostics solutions provider

Biotechnology
Healthcare

Compensation Overview

$180k - $200kAnnually

Senior

Company Historically Provides H1B Sponsorship

Boston, MA, USA

The territory covers Boston, MA and surrounding area.

Category
Field Sales
Sales & Account Management
Required Skills
Sales

You match the following Natera's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • Bachelor’s Degree or equivalent educational background.
  • A minimum of 6 years of progressive sales experience, ideally within the diagnostic or lab-developed test industry.
  • Proven track record of closing sales, building client relationships, and driving revenue growth.
  • Existing relationships with key opinion leaders (KOLs) in nephrology or specialty medicine.
  • Knowledge of academic medical systems and large hospital systems (IDNs) related to nephrology or specialty medicine.
  • Travel up to 50% - 75% within territory.
Responsibilities
  • Achieve and exceed performance goals through effective sales strategies, client relationship building, and territory management.
  • Drive market adoption of Natera’s products, contributing to successful product launches and market expansion.
  • Serve as a local expert on Natera’s technology and services, representing the company with professionalism and technical expertise.
  • Develop and execute tailored local business plans to achieve sales objectives and maximize available resources.

Natera specializes in genetic testing and diagnostics within the healthcare sector. The company uses cell-free DNA (cfDNA) testing to analyze small DNA fragments in the blood, which helps in detecting minimal traces of cancer in patients, guiding treatment decisions. One of their key products is the Signatera test, a custom ctDNA test for cancer patients, available through a remote access program. Natera also focuses on organ health for transplant patients, using cfDNA testing to monitor transplanted organs for potential issues. Additionally, they provide tests for women's health, including family planning and prenatal screening, with their Panorama NIPT being a notable product that has conducted over 2 million tests. Natera differentiates itself by offering specialized testing services directly to healthcare providers and patients, along with genetic counseling services. The company's goal is to enhance patient care through advanced genetic testing solutions.

Company Stage

IPO

Total Funding

$149.9M

Headquarters

Austin, Texas

Founded

2004

Growth & Insights
Headcount

6 month growth

0%

1 year growth

0%

2 year growth

10%
Simplify Jobs

Simplify's Take

What believers are saying

  • Increased adoption of liquid biopsy techniques boosts demand for Natera's cfDNA tests.
  • AI integration enhances accuracy and speed of Natera's cfDNA analysis.
  • Growing personalized medicine trend aligns with Natera's customized genetic tests.

What critics are saying

  • Hindenburg report accuses Natera of deceptive sales practices, risking legal challenges.
  • New Prospera Heart features may face slow adoption by healthcare providers.
  • Fetal RhD NIPT demand may drop post-RhIg shortage, affecting future sales.

What makes Natera unique

  • Natera's Signatera test offers personalized ctDNA analysis for cancer patients.
  • Prospera Heart test uses unique Donor Quantity Score for transplant rejection detection.
  • Panorama NIPT test is a leader in non-invasive prenatal testing with 2 million tests.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible medical plans

Investment options

Time off

Workplace perks